---
title: "30 stocks will face lifting of restrictions next week"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263759112.md"
description: "Next week, 30 stocks will be unlocked, with a total unlocked market value of 20.322 billion yuan. Huaxia Eye will unlock 511 million shares, with a market value of 9.993 billion yuan, the highest unlock scale. Yunding Tech will unlock 153 million shares, with a market value of 1.74 billion yuan, the second highest unlock scale. Huaxia Eye has the highest unlock ratio, reaching 60.85%"
datetime: "2025-10-31T13:16:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263759112.md)
  - [en](https://longbridge.com/en/news/263759112.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263759112.md)
generator: "portal-rs"
---

# 30 stocks will face lifting of restrictions next week

According to statistics, 30 stocks will be unlocked next week, with a total unlock market value of 20.322 billion yuan based on the latest closing prices. Huaxia Eye will have 511 million shares listed for circulation next week, mainly consisting of the original shareholders' restricted shares from the initial public offering, with an unlock market value of 9.993 billion yuan, the highest unlock market value scale. Yunding Tech's unlock scale is second, with 153 million shares listed for circulation next week, mainly consisting of shares allocated to institutional investors from a targeted placement, with an unlock market value of 1.74 billion yuan. In terms of unlock ratio, Huaxia Eye has the highest unlock ratio at 60.85%, followed by Hongbo Pharmaceutical, Naike Equipment, Yunding Tech, Ruina Intelligent, and Gangdi Technology

### Related Stocks

- [301267.CN](https://longbridge.com/en/quote/301267.CN.md)
- [000409.CN](https://longbridge.com/en/quote/000409.CN.md)

## Related News & Research

- [16:01 ETFoventa further strengthens management team with key CMO and CFO appointments](https://longbridge.com/en/news/297823550.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [11:16 ETJarrow Formulas® Launches Gut & Protein Optimizer and NMN 300 mg to Support Protein Absorption, Cellular Energy and Healthy Aging](https://longbridge.com/en/news/297672016.md)
- [Galle Face Capital Partners publishes annual report for year ended March 31, 2026](https://longbridge.com/en/news/297586883.md)
- [08:53 ETCeraVe Takes a Skin-Barrier First Approach to Aging with New Super Boost Serum To Fight 5 Signs of Aging](https://longbridge.com/en/news/297789621.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**